Stocks ITRN Financial statements
Financial statementsIturan Location & Control Ltd. financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Ituran Location & Control Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 200 | 235 | 253 | 279 | 246 | 271 | 293 | 320 | 336 | 359 |
| Cost of revenue | 97.5 | 115 | 126 | 149 | 129 | 143 | 156 | 167 | 176 | 180 |
| Gross profit | 102 | 119 | 127 | 131 | 117 | 128 | 138 | 153 | 161 | 179 |
| Research and development | 2.9 | 3.16 | 6.22 | 13.9 | 12.8 | 14.1 | 16.8 | 17 | 18.1 | 20.8 |
| Selling and marketing | 10.1 | 12.2 | 11.3 | 12.8 | 12 | 13.3 | 13.3 | 13.6 | 15.3 | 18.4 |
| General and administrative | 40.2 | 47.6 | 47.7 | 55.2 | 49.7 | 46.1 | 48.7 | 56.6 | 56.2 | 62.5 |
| Operating income | 48 | 56.5 | 62.4 | 22.7 | 27.8 | 54.6 | 58.8 | 66 | 71.2 | 77 |
| Other non-operating income | 2.06 | -0.99 | 0.72 | 0.58 | 1.48 | -5.54 | -5.94 | -1.55 | 0.08 | -1.85 |
| Pre-tax income | 50.1 | 55.5 | 76.2 | 23.2 | 29 | 49 | 52.8 | 64.4 | 71.2 | 74.9 |
| Income tax | 14.9 | 17.7 | 17.3 | 12.2 | 10.9 | 11.9 | 12.7 | 13.4 | 14.6 | 14.9 |
| Net income to minority interests | 2.59 | 2.57 | 2.5 | 0.88 | 1.22 | 2.76 | 2.4 | 2.21 | 2.89 | 2.03 |
| Net income | 32.1 | 43.8 | 60.7 | 6.89 | 16.1 | 34.3 | 37.1 | 48.1 | 53.7 | 58 |
| EBITDA | 57.2 | 66.9 | 71.5 | 39.8 | 42.3 | 68.2 | 73.4 | 80.7 | 86 | 90.8 |
| EPS, basic | 1.53 | 2.09 | 2.88 | 0.33 | 0.77 | 1.65 | 1.82 | 2.41 | 2.70 | 2.92 |
| EPS, diluted | 1.53 | 2.09 | 2.88 | 0.33 | 0.77 | 1.65 | 1.82 | 2.41 | 2.70 | 2.92 |
| Shares, basic (weighted) | 21 | 21 | 21.1 | 21 | 20.8 | 20.8 | 20.4 | 20 | 19.9 | 19.9 |
| Shares, diluted (weighted) | 21 | 21 | 21.1 | 21 | 20.8 | 20.8 | 20.4 | 20 | 19.9 | 19.9 |
| Dividend per share | 0.90 | 0.56 | 0.68 | 1.56 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 31.1 | 36.9 | 51.4 | 54 | 72.2 | 50.3 | 27.9 | 53.4 | 77.4 | 108 |
| Short-term investments | 0.4 | 3.56 | 1.9 | 0.36 | 6.66 | 4.41 | 0.32 | 0.12 | 0.01 | 0 |
| Receivables | 33.9 | 41 | 54.3 | 45.1 | 39.3 | 43.9 | 45.8 | 45.4 | 47.7 | 58.5 |
| Inventory | 14.4 | 14.2 | 28.4 | 25.5 | 22.6 | 27.1 | 28.5 | 26.9 | 23.4 | 23.2 |
| Other current assets | 31.5 | 41.4 | 53 | 49.2 | 38.6 | 37 | 48.2 | 52.7 | 46.1 | 48.4 |
| Total current assets | 111 | 137 | 189 | 174 | 179 | 163 | 151 | 179 | 195 | 238 |
| Property, plant and equipment | 35.6 | 39 | 50.5 | 45.9 | 37.7 | 35.7 | 45.6 | 42 | 33.1 | 39.4 |
| Lease right-of-use assets | 12.6 | 5.55 | 4.69 | 9.91 | 8.07 | 8.95 | 8.88 | |||
| Goodwill | 3.41 | 3.78 | 62.9 | 50.1 | 39.9 | 40 | 39.5 | 39.4 | 39.3 | 39.8 |
| Intangible assets | 0.02 | 0.04 | 39 | 26.3 | 19.9 | 16.8 | 12.6 | 10.8 | 9.01 | 8.84 |
| Other non-current assets | 1.52 | 0.94 | 3.22 | 3.37 | 2.95 | 3.15 | 3.13 | 3.99 | 5.85 | 5.41 |
| Total assets | 178 | 215 | 374 | 339 | 312 | 293 | 291 | 319 | 327 | 386 |
| Accounts payable | 18.6 | 23.3 | 24 | 22.7 | 19.7 | 21.3 | 21.9 | 20.8 | 18.8 | 19.1 |
| Accrued liabilities | 11 | 12.8 | 10.3 | 7.66 | 16 | 15 | 11.9 | 15.7 | 14.8 | 19.4 |
| Deferred revenue | 10.8 | 12.8 | 37.7 | 29.1 | 24.4 | 24.3 | 21.8 | 27.1 | 22.9 | 27.2 |
| Short-term debt | 0.05 | 8.35 | 18.1 | 19.5 | 17.6 | 11.6 | 0.36 | 0.11 | 0 | |
| Total current liabilities | 56.1 | 65.8 | 105 | 101 | 113 | 104 | 93 | 92.5 | 87.7 | 104 |
| Lease liabilities | 10.8 | 2.69 | 1.75 | 6.89 | 4.77 | 5.56 | 4.75 | |||
| Other non-current liabilities | 0.5 | 0.48 | 0.53 | 0.24 | 2.34 | 2.34 | 2.07 | 2.03 | 2.1 | 2.39 |
| Total liabilities | 69.8 | 81.9 | 214 | 203 | 183 | 155 | 138 | 138 | 136 | 162 |
| Total debt | 71 | 67.9 | 54.5 | 31.4 | 12.2 | 0.59 | ||||
| Paid-in capital | 71.6 | 71.6 | 78.7 | 78.7 | 78.3 | 78.3 | 78.4 | 78.4 | 78.4 | 78.4 |
| Retained earnings | 71.7 | 92.1 | 130 | 116 | 128 | 143 | 169 | 204 | 226 | 244 |
| Treasury stock | -30.1 | -30.1 | -25.1 | -41.9 | -41.9 | -49.2 | -57.7 | -64.3 | -64.3 | -67.4 |
| Other comprehensive income | -13 | -9.75 | -20.6 | -25.9 | -38.8 | -41.9 | -45.8 | -45.2 | -57 | -39.8 |
| Shareholders' equity | 102 | 126 | 154 | 129 | 127 | 132 | 146 | 174 | 185 | 218 |
| Minority interests | 5.94 | 7.44 | 6.51 | 6.58 | 2.71 | 5.34 | 7.06 | 5.8 | 6.03 | 6.92 |
| Total equity | 108 | 133 | 160 | 136 | 130 | 138 | 153 | 180 | 191 | 224 |
| Total liabilities and equity | 178 | 215 | 374 | 339 | 312 | 293 | 291 | 319 | 327 | 386 |
| Shares outstanding | 23.5 | 23.5 | 23.5 | 23.5 | 23.5 | 23.5 | 23.5 | 23.5 | 23.5 | 23.5 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 34.7 | 46.4 | 63.2 | 7.77 | 17.3 | 37 | 39.5 | 50.3 | 56.5 | 60 |
| Depreciation and amortization | 9.16 | 10.4 | 9.12 | 17.2 | 14.5 | 13.6 | 14.6 | 14.8 | 14.9 | 13.8 |
| Deferred income tax | -1.09 | -2.15 | 2.35 | -2.25 | -2.16 | -0.44 | -0.74 | -3.13 | -0.38 | -1.61 |
| Change in receivables | -4.55 | -4.77 | 6.18 | 10.7 | 4.5 | -3.99 | -5.1 | -0.03 | -5.23 | -3.73 |
| Change in inventory | -1.42 | 1.63 | 3.58 | 3.82 | 3.12 | -3.84 | -5.84 | 1.1 | 3.37 | 2.61 |
| Change in payables | 5.88 | 3.75 | -3.84 | -1.13 | -0.66 | 1.78 | 1.42 | -1.86 | 0.18 | -2.14 |
| Cash from operations | 41.5 | 43.9 | 53.3 | 59.7 | 60.1 | 55.8 | 45.1 | 77.2 | 74.3 | 88.6 |
| Capital expenditures | -13.6 | -16.2 | -21.7 | -18.3 | -10.2 | -16.6 | -26.5 | -14.2 | -13.6 | -21.8 |
| Purchases of investments | -3.15 | -8.62 | -8.1 | -1.1 | 0 | 0 | -0.1 | 0 | 0 | |
| Sales and maturities of investments | 4.63 | 5.37 | 9.59 | 2.4 | 0.27 | 0 | 0 | 0.1 | 0 | 0 |
| Cash from investing | -19.9 | -14.7 | -84.9 | -18.3 | -11.5 | -18.5 | -27.4 | -17.2 | -15.9 | -24.2 |
| Debt repaid | -7.99 | -8.94 | -18.2 | -23.8 | -16.5 | -11.7 | 0 | 0 | ||
| Dividends paid | -17.1 | -22.6 | -20.2 | -19.8 | -9.97 | -15.8 | -11.5 | -11.6 | -28.1 | -37.6 |
| Cash from financing | -18.2 | -24.3 | 49.8 | -38.9 | -29.4 | -58.7 | -36.4 | -32.9 | -31.8 | -42.7 |
| Exchange rate effect | 0.69 | 0.86 | -3.69 | 0.1 | -0.92 | -0.48 | ||||
| Net change in cash | 4.07 | 5.82 | 14.5 | 2.57 | 18.2 | -21.9 | -22.5 | 25.6 | 23.9 | 30.2 |
| Free cash flow | 27.8 | 27.7 | 31.5 | 41.4 | 49.8 | 39.2 | 18.6 | 63 | 60.6 | 66.8 |
| Interest paid | 0.32 | 2.65 | 1.27 | 1.79 | 1.96 | 0.98 | 0.71 | 0.36 | 0.02 | 0 |
| Income taxes paid | 17.7 | 22.9 | 15.5 | 10.4 | 14.4 | 13.5 | 11.1 | 10.9 | 14.8 | 16.7 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 49.7% | Gross profit / revenue. |
| Operating margin | 21.5% | Operating income / revenue. |
| EBITDA margin | 25.3% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 20.9% | Pre-tax income / revenue. |
| Net margin | 16.1% | Net income / revenue. |
| FCF margin | 18.6% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 24.7% | Cash from operations / revenue. |
| Effective tax rate | 19.9% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 28.8% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 16.3% | Net income / average total assets. |
| Return on invested capital (ROIC) | 56.6% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 5.8% | Research and development expense / revenue. |
| Capex / revenue | 6.1% | Capital expenditures / revenue. |
| D&A / revenue | 3.8% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 6.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 7.0% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 7.9% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 11.2% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 9.1% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 8.9% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 8.2% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 9.4% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 22.6% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 5.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 7.3% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 16.5% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 8.0% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 16.0% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 29.2% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 8.1% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 17.1% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 30.6% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 19.3% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 25.2% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 8.1% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 10.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 53.1% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 6.0% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 17.5% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 14.3% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 11.3% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 18.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 9.9% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 4.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -0.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -0.9% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -0.9% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.28x | Current assets / current liabilities. |
| Quick ratio | 1.60x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.03x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 41.9% | Total liabilities / total assets. |
| Working capital | $133.5M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 12.6% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $168.9M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.01x | Revenue / average total assets. |
| Fixed asset turnover | 9.91x | Revenue / average property, plant and equipment. |
| Inventory turnover | 7.74x | Cost of revenue / average inventory. |
| Days inventory | 47 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 6.76x | Revenue / average receivables. |
| Days sales outstanding | 54 days | 365 x average receivables / revenue. |
| Days payables | 38 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 63 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 115.2% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 24.6% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $2.92 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $2.92 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $18.07 | Revenue / diluted weighted shares. |
| FCF per share | $3.36 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $4.46 | Cash from operations / diluted weighted shares. |
| Book value per share | $9.27 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $7.19 | Tangible book value / shares outstanding. |
| Cash per share | $4.58 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 64.8% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 56.3% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.03B | Share price x shares outstanding. |
| Enterprise value | $920.7M | Market cap + total debt - cash - short-term investments. |
| P/E | 17.7x | Market cap / net income. Only when net income is positive. |
| P/S | 2.86x | Market cap / revenue. |
| P/B | 4.73x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 6.09x | Market cap / tangible book value, when positive. |
| P/FCF | 15.4x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 11.6x | Market cap / cash from operations, when positive. |
| EV/Sales | 2.56x | Enterprise value / revenue. |
| EV/EBIT | 12.0x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 10.1x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 13.8x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 6.5% | Free cash flow / market cap. |
| Earnings yield | 5.6% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 3.7% | Dividends paid over the period / market cap. |
| Shareholder yield | 3.7% | (Dividends paid + share buybacks) / market cap. |
| PEG | 1.04x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was Ituran Location & Control Ltd.'s revenue in fiscal 2025?
Ituran Location & Control Ltd. reported revenue of $359.0M for fiscal 2025, 6.8% higher than the year before.
Was Ituran Location & Control Ltd. profitable in fiscal 2025?
Yes. Net income was $58.0M, a net margin of 16.1%.
How much free cash flow did Ituran Location & Control Ltd. generate in fiscal 2025?
Cash from operations of $88.6M minus capital expenditures of $21.8M left free cash flow of $66.8M.